Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Nature Communications|August 6, 2021
Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatmentSandra S Ring, Jovana Cupovic, Lucas Onder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2020
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA AntibodiesOmar Hasan Ali, David Bomze, Lorenz Risch, et al.
Clinical Chemistry and Laboratory Medicine|September 1, 2020
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based studyRita Christiane Baron, Lorenz Risch, Myriam Weber, et al.
Ebiomedicine|June 9, 2023
Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastasesEftychia Chatziioannou, Jana Roßner, Thazin New Aung, et al.
Cancer Discovery|May 20, 2021
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with CancerTatjana Bilich, Malte Roerden, Yacine Maringer, et al.
Virchows Archiv : an International Journal of Pathology|June 18, 2024
Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control studyStephan Forchhammer, Oltin Tiberiu Pop, Matthias Hahn, et al.
Nature Medicine|February 9, 2010
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunityLukas Flatz, Ahmed N Hegazy, Andreas Bergthaler, et al.
Ebiomedicine|August 30, 2020
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanomaAnne Fröhlich, Judith Sirokay, Simon Fietz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2024
A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature researchTeresa Amaral, Lena Nanz, Lina Maria Serna Higuita, et al.
Journal for Immunotherapy of Cancer|December 22, 2021
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapyJonas Bochem, Henning Zelba, Janine Spreuer, et al.
Pageof 13